9 articles, transcripts, and reports
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in…
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 2021 earnings call dated Jul. 28, 2021. Corporate Participants: Kevin C. Mannix — Senior Vice President, Head of Investor…
Teva Pharmaceuticals’ (NYSE: TEVA) reported first-quarter 2021 results today before the opening bell. The company dropped its revenue by 9% to $3.98 billion year on…
Teva Pharmaceuticals (NYSE: TEVA) beat Q2 earnings estimates, but fell short of Street’s revenue targets. The drug manufacturer reported adjusted EPS of $0.53 on revenue…
Teva Pharmaceutical Industries Limited (TEVA) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Kevin C. Mannix — Senior Vice President, Investor Relations Kare Schultz — Director and…
Teva Pharmaceuticals’ (NYSE: TEVA) first quarter 2020 results beat consensus estimates. The drugmaker reported adjusted earnings of $0.76 per share on revenue of $4.4 billion.…
Teva Pharmaceutical Industries Limited (NYSE: TEVA) Q4 2019 Earnings Conference Call February 12, 2020 Corporate participants: Kevin C. Mannix — Senior Vice President, Investor Relations Kare Schultz — President…
Shares of Teva Pharmaceuticals (NYSE: TEVA) fell to a new low this month as markets across the world continued to be battered by the raging…
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) swung to a profit in the fourth quarter of 2019 from a loss last year, helped by lower costs…
